{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:49:48Z","timestamp":1791319788910,"version":"4.3.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005977","name":"Kaiser Permanente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ygyno.2026.09.013","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:22:42Z","timestamp":1790886162000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort"],"prefix":"10.1016","volume":"214","author":[{"given":"Elizabeth","family":"Suh-Burgmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Finertie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yi","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hoodfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Carwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Schmittdiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.09.013_bb0005","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/PO.21.00249","article-title":"Ohio Prevention and Treatment of Endometrial Cancer Initiative Study Group. Up-front multigene panel testing for cancer susceptibility in patients with newly diagnosed endometrial cancer: a multicenter prospective study","volume":"5","author":"Levine","year":"2021","journal-title":"JCO Precis. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.09.013_bb0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/djad016","article-title":"Comprehensive analysis of germline drivers in endometrial cancer","volume":"115","author":"Gordhandas","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2026.09.013_bb0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ygyno.2022.05.023","article-title":"Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer","volume":"166","author":"Heald","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.09.013_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2025.04.585","article-title":"Pathogenic germline variants among women with uterine cancer by ancestry: a commercial laboratory collaborative research registry study","volume":"197","author":"Johnson","year":"2025","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2026.09.013_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","article-title":"A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients","volume":"17","author":"Klabunde","year":"2007","journal-title":"Ann. Epidemiol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.09.013_bb0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s11524-006-9094-x","article-title":"The development of a standardized neighborhood deprivation index","volume":"83","author":"Messer","year":"2006","journal-title":"J. Urban Health"},{"key":"10.1016\/j.ygyno.2026.09.013_bb0035","series-title":"Summary Stage 2018: Codes and Coding Instructions","year":"2021"},{"issue":"10","key":"10.1016\/j.ygyno.2026.09.013_bb0040","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41436-019-0536-8","article-title":"The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis","volume":"21","author":"Ryan","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2026.09.013_bb0045","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.ygyno.2026.09.013_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2015.12.034","article-title":"Germline mutations of the DNA repair pathways in uterine serous carcinoma","volume":"141","author":"Frimer","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.09.013_bb0055","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-18-1443","article-title":"Frequent homologous recombination deficiency in high-grade endometrial carcinomas","volume":"25","author":"de Jonge","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.ygyno.2026.09.013_bb0060","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1200\/JCO.22.02378","article-title":"Clinical multigene panel testing identifies racial and ethnic differences in germline pathogenic variants among patients with early-onset colorectal cancer","volume":"41","author":"Seagle","year":"2023","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:50:01Z","timestamp":1791316201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826021384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":12,"alternative-id":["S0090825826021384"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.09.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}